Company Update Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals Limited receives Final Approval for Amlodipine and Atorvastatin Tablets USP 2.5 mg/ 10 mg, 2.5 mg / 20 mg, 2.5 mg / 40 mg, 5 mg / 10 mg, 5 mg / 20 mg, 5 mg / 40 mg, 5 mg / 80 mg, 10 mg / 10 mg, 10 mg / 20 mg, 10 mg / 40mg, and 10 mg / 80 mg.